Skip to content

National Registry of Hepatic Metastases From Non-Colorectal Cancer

REGISTRO NACIONAL DE METÁSTASIS HEPÁTICAS DE CÁNCER NO COLORRECTAL

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07180641
Acronym
REMENOCOR
Enrollment
1039
Registered
2025-09-18
Start date
2010-01-01
Completion date
2022-12-31
Last updated
2025-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatectomy, Liver Metastases, Liver Metastasis, Liver Resection, Non-colorectal Liver Metastases, Non-colorectal Liver Metastasis, Non-neuroendocrine Liver Metastases, Non-neuroendocrine Liver Metastasis

Keywords

Non-colorectal non-neuroendocrine liver metastases, Liver metastases, Liver resection, Hepatectomy

Brief summary

The investigators designed this observational, retrospective, multicenter study including all patients who underwent surgery for non-colorectal liver metastases between January 2010 and December 2022, with the aim of establishing a series of recommendations for the treatment of liver metastases from various extrahepatic primary tumors

Interventions

None listed

Sponsors

Clinica Universidad de Navarra, Universidad de Navarra
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for liver surgery due to non-colorectal liver metastases, regardless of the primary tumor origin, via open or minimally invasive approach

Exclusion criteria

* Patients undergoing surgery for colorectal liver metastases, emergency surgical interventions and patients younger than 18 years old.

Design outcomes

Primary

MeasureTime frameDescription
Overall Survival5 years from liver resectionTime from the date of liver resection for non-colorectal metastases to death from any cause. Survival will be assessed for up to 5 years postoperatively
Progression-Free Survival5 years from surgeryTime from the date of liver resection for non-colorectal metastases to the date of documented disease progression or death from any cause, whichever occurs first. Patients without progression or death will be censored at the last follow-up

Secondary

MeasureTime frameDescription
Recurrence PatternUp to 5 years from liver resectionDistribution and characterization of tumor recurrence (hepatic, extrahepatic, or both) after liver resection for non-colorectal metastases.
Postoperative Morbidity Rate90 days from surgeryIncidence of any postoperative complications occurring within 90 days after liver resection, including but not limited to infections, bleeding, bile leaks, and other surgical complications, classified according to standard criteria.
R0 Resection RateAt surgeryProportion of patients achieving complete microscopic liver tumor resection (R0) during liver resection
Length of hospital stayPerioperative/PeriproceduralNumber of days from surgery to discharge following liver resection
Postoperative Mortality Rate90 days from surgeryProportion of patients who die from any cause within 90 days following liver resection surgery.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026